Skip to content

Clinical trials

Completed Phase 2 Hematologic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Phase 2 Status: Completed Clear all

111 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20025
20032
20045
20053
20063
20075
20087
200910
20105
20117
20124
201310
20143
20157
20167
20174
20186
20192
20203
20214
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed111

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center12
National Cancer Institute (NCI)8
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University6
Fred Hutchinson Cancer Center5
Novartis Pharmaceuticals5
Stanford University4
Medical College of Wisconsin3
University of Liege3
Bristol-Myers Squibb2
Dana-Farber Cancer Institute2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms111
Multiple Myeloma25
Leukemia22
Leukemia, Myeloid, Acute21
Graft vs Host Disease19
Lymphoma19
Precursor Cell Lymphoblastic Leukemia-Lymphoma18
Myelodysplastic Syndromes17
Hodgkin Disease16
Neoplasms13

Trials

Showing 1 to 25 of 111. Each trial links to its page on Pharma Observatory.

11 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.